A study analyzing the data at our hospital about use of Nodify test to see cost effectiveness of test in management of the intermediate risk nodules. The objective is to calculate sensitivity, specificity, positive predictive value and negative predictive value at our facility for both Nodify-CDT and CDT-XL2 tests.
Official Title
Cross sectional study analyzing the role of Nodify-CDT and Nodify-XL2 blood biomarkers as a tool to make decision for lung biopsy for pulmonary nodules in a community hospital in Southern California
Mehul Patel, MD, is board certified in pulmonary and critical care medicine and sees patients at the Eisenhower Pulmonary and Critical Care Clinic in Rancho Mirage.
Dr. Patel completed his residency program in Internal Medicine at Eisenhower Health and then a fellowship program in pulmonary and critical care medicine at Parkview Medical Center in Pueblo, CO, where he served as chief fellow.
Dr. Patel was born in India and raised in the United States. During visits to India, he saw the lack... more
less
Mehul Patel, MD, is board certified in pulmonary and critical care medicine and sees patients at the Eisenhower Pulmonary and Critical Care Clinic in Rancho Mirage.
Dr. Patel completed his residency program in Internal Medicine at Eisenhower Health and then a fellowship program in pulmonary and critical care medicine at Parkview Medical Center in Pueblo, CO, where he served as chief fellow.
Dr. Patel was born in India and raised in the United States. During visits to India, he saw the lack of basic health care for people who were very sick. “Seeing the high cost and lack of health care for very poor and sick people had a significant impact on my decision to become a physician,” states Dr. Patel. In addition, a family friend and mentor inspired Dr. Patel to pursue medicine as a career and calling.
During a critical care rotation in his fourth year of medical school, Dr. Patel became interested in pursuing pulmonology and critical care as a specialty. “I loved the fast-paced, hands-on nature of caring for people who were critically ill and in the ICU.”
Dr. Patel strives to maximize outcomes for his patients with chronic pulmonary diseases. “Often these diseases are not curable, so my job –with input from my patients - is to hone a treatment plan that affords them with the best quality of life possible.”